NICOLE BURCHETT: Open Payments
NPI 1487207973 · PAINTSVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$960 in 44 payments from 14 companies in 2025. Trend: 2023 $647 · 2024 $515 · 2025 $960
Food & beverage: $960
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $352 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $157 |
| Amgen Inc. | 8 | $137 |
| Dexcom, Inc. | 1 | $45 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| Novartis Pharmaceuticals Corporation | 2 | $35 |
| PFIZER INC. | 2 | $32 |
| Novo Nordisk Inc | 1 | $30 |
| SHIELD THERAPEUTICS INC | 1 | $26 |
Products named: Kerendia, QULIPTA, OTEZLA, UBRELVY, Dexcom G6 Transmitter, TRELEGY ELLIPTA, CAPLYTA, LEQVIO.
Industry payments across KY — which companies pay providers there.
